{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:25:40Z","timestamp":1787243140367,"version":"build-2736575974"},"reference-count":101,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T00:00:00Z","timestamp":1778457600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001273","name":"Children with Cancer UK","doi-asserted-by":"publisher","award":["19-313"],"award-info":[{"award-number":["19-313"]}],"id":[{"id":"10.13039\/501100001273","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005303","name":"Boston College","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005303","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.xcrm.2026.102845","type":"journal-article","created":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T15:11:12Z","timestamp":1781622672000},"page":"102845","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Ketogenic diet as a metabolic vehicle enhancing the therapeutic efficacy of mebendazole and devimistat in juvenile syngeneic high-grade glioma"],"prefix":"10.1016","volume":"7","author":[{"given":"Purna","family":"Mukherjee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack","family":"Maurer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylwia A.","family":"Stopka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bennett","family":"Greenwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan J.","family":"Aristizabal-Henao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srada","family":"Karmacharya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Chimento","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Ta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek C.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Duraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roderick T.","family":"Bronson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Kiebish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1491-3989","authenticated-orcid":false,"given":"Thomas N.","family":"Seyfried","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2026.102845_bib1","first-page":"1","article-title":"Brain tumours: rise in glioblastoma multiforme incidence in England 1995\u20132015 suggests an adverse environmental or lifestyle factor","volume":"2018","author":"Philips","year":"2018","journal-title":"J. Environ. Public Health"},{"key":"10.1016\/j.xcrm.2026.102845_bib2","article-title":"Rising incidence of glioblastoma multiforme in a well-defined population","volume":"12","author":"Grech","year":"2020","journal-title":"Cureus"},{"key":"10.1016\/j.xcrm.2026.102845_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.593192","article-title":"Canadian pediatric neuro-oncology standards of practice","volume":"10","author":"Bennett","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.xcrm.2026.102845_bib4","first-page":"10","article-title":"Cancer statistics, 2012","volume":"62","author":"Siegel","year":"2012","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.xcrm.2026.102845_bib5","first-page":"17","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.xcrm.2026.102845_bib6","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s11060-014-1653-5","article-title":"Pediatric supratentorial high-grade glioma: multicenter retrospective observational study of the Korean Society for Pediatric Neuro-Oncology","volume":"121","author":"Jung","year":"2015","journal-title":"J. Neuro Oncol."},{"key":"10.1016\/j.xcrm.2026.102845_bib7","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1093\/nop\/npu022","article-title":"Management of high-grade gliomas in the pediatric patient: past, present, and future","volume":"1","author":"Vanan","year":"2014","journal-title":"Neuro-Oncol. Pract."},{"key":"10.1016\/j.xcrm.2026.102845_bib8","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s11060-022-03976-y","article-title":"Correction to: central nervous system tumors in children under 5 years of age: a report on treatment burden, survival and long-term outcomes","volume":"157","author":"Metzger","year":"2022","journal-title":"J. Neuro Oncol."},{"key":"10.1016\/j.xcrm.2026.102845_bib9","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s11060-018-03084-w","article-title":"Neurological predictor scale is associated with academic achievement outcomes in long-term survivors of childhood brain tumors","volume":"142","author":"Kautiainen","year":"2019","journal-title":"J. Neuro Oncol."},{"key":"10.1016\/j.xcrm.2026.102845_bib10","doi-asserted-by":"crossref","first-page":"x1","DOI":"10.1093\/neuonc\/nou327","article-title":"Alex\u2019s Lemonade Stand Foundation infant and childhood primary brain and central nervous system tumors diagnosed in the United States in 2007\u20132011","volume":"16","author":"Ostrom","year":"2015","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.xcrm.2026.102845_bib11","article-title":"In vivo and ex vivo pediatric brain tumor models: an overview","volume":"11","author":"Li","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.xcrm.2026.102845_bib12","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/sj.bjc.6603402","article-title":"Secondary dissemination in children with high-grade malignant gliomas and diffuse intrinsic pontine gliomas","volume":"95","author":"Wagner","year":"2006","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.xcrm.2026.102845_bib13","doi-asserted-by":"crossref","first-page":"622","DOI":"10.3171\/jns.2005.102.4.0622","article-title":"Prognostic significance of intracranial dissemination of glioblastoma multiforme in adults","volume":"102","author":"Parsa","year":"2005","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.xcrm.2026.102845_bib14","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s11060-006-9313-z","article-title":"Pattern of recurrence in pediatric malignant glioma: an institutional experience","volume":"83","author":"Vaidya","year":"2007","journal-title":"J. Neuro Oncol."},{"key":"10.1016\/j.xcrm.2026.102845_bib15","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3171\/jns.1979.50.3.0305","article-title":"Macrophages in experimental and human brain tumors. Part 2: studies of the macrophage content of human brain tumors","volume":"50","author":"Morantz","year":"1979","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.xcrm.2026.102845_bib16","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1007\/s00401-014-1272-4","article-title":"Human pontine glioma cells can induce murine tumors","volume":"127","author":"Caretti","year":"2014","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.xcrm.2026.102845_bib17","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1097-0215(19990702)82:1<12::AID-IJC3>3.0.CO;2-O","article-title":"Microglial\/macrophage expression of interleukin 10 in human glioblastomas","volume":"82","author":"Wagner","year":"1999","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.xcrm.2026.102845_bib18","doi-asserted-by":"crossref","DOI":"10.1042\/AN20110011","article-title":"Hypothesis: are neoplastic macrophages\/microglia present in glioblastoma multiforme?","volume":"3","author":"Huysentruyt","year":"2011","journal-title":"ASN Neuro"},{"key":"10.1016\/j.xcrm.2026.102845_bib19","doi-asserted-by":"crossref","first-page":"12","DOI":"10.21037\/lcm-21-43","article-title":"The glucose ketone index predicts overall survival and metastasis of mouse tumor cells to visceral organs and brain","volume":"5","author":"Akgoc","year":"2022","journal-title":"Long Chin Med"},{"key":"10.1016\/j.xcrm.2026.102845_bib20","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/ijc.23492","article-title":"Metastatic cancer cells with macrophage properties: evidence from a new murine tumor model","volume":"123","author":"Huysentruyt","year":"2008","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.xcrm.2026.102845_bib21","doi-asserted-by":"crossref","DOI":"10.1042\/AN20100002","article-title":"Calorie restriction as an anti-invasive therapy for malignant brain cancer in the VM mouse","volume":"2","author":"Shelton","year":"2010","journal-title":"ASN Neuro"},{"key":"10.1016\/j.xcrm.2026.102845_bib22","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1177\/1043454213520191","article-title":"Quality of life and symptoms in pediatric brain tumor survivors: a systematic review","volume":"31","author":"Macartney","year":"2014","journal-title":"J. Pediatr. Oncol. Nurs."},{"key":"10.1016\/j.xcrm.2026.102845_bib23","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1177\/0883073808321765","article-title":"Chemotherapy for malignant brain tumors of childhood","volume":"23","author":"Gottardo","year":"2008","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.xcrm.2026.102845_bib24","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1093\/neuonc\/noq205","article-title":"Temozolomide in the treatment of children with newly diagnosed diffuse intrinsic pontine gliomas: a report from the Children's Oncology Group","volume":"13","author":"Cohen","year":"2011","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.xcrm.2026.102845_bib25","first-page":"4","article-title":"Temozolomide for Paediatric High-Grade Glioma: Time for a Rethink?","volume":"19","author":"Staunton","year":"2023","journal-title":"J Pediatr Oncol"},{"key":"10.1016\/j.xcrm.2026.102845_bib26","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s11060-020-03431-w","article-title":"The contribution of ketone bodies to glycolytic inhibition for the treatment of adult and pediatric glioblastoma","volume":"147","author":"Vallejo","year":"2020","journal-title":"J. Neuro Oncol."},{"key":"10.1016\/j.xcrm.2026.102845_bib27","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1007\/s11064-019-02795-4","article-title":"Provocative Question: Should Ketogenic Metabolic Therapy Become the Standard of Care for Glioblastoma?","volume":"44","author":"Seyfried","year":"2019","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.xcrm.2026.102845_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.968351","article-title":"Metabolic management of microenvironment acidity in glioblastoma","volume":"12","author":"Seyfried","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.xcrm.2026.102845_bib29","doi-asserted-by":"crossref","DOI":"10.1177\/1759091418818261","article-title":"Mitochondrial substrate-level phosphorylation as energy source for glioblastoma: review and hypothesis","volume":"10","author":"Chinopoulos","year":"2018","journal-title":"ASN Neuro"},{"key":"10.1016\/j.xcrm.2026.102845_bib30","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s40170-020-00215-8","article-title":"Glutamine uptake and utilization of human mesenchymal glioblastoma in orthotopic mouse model","volume":"8","author":"Oizel","year":"2020","journal-title":"Cancer Metab."},{"key":"10.1016\/j.xcrm.2026.102845_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2020.101761","article-title":"On the origin of ATP synthesis in cancer","volume":"23","author":"Seyfried","year":"2020","journal-title":"iScience"},{"key":"10.1016\/j.xcrm.2026.102845_bib32","doi-asserted-by":"crossref","DOI":"10.1080\/17590914.2024.2422268","article-title":"Amino acid and glucose fermentation maintain ATP content in mouse and human malignant glioma cells","volume":"16","author":"Lee","year":"2024","journal-title":"ASN Neuro"},{"key":"10.1016\/j.xcrm.2026.102845_bib33","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s42003-019-0455-x","article-title":"Therapeutic benefit of combining calorie-restricted ketogenic diet and glutamine targeting in late-stage experimental glioblastoma","volume":"2","author":"Mukherjee","year":"2019","journal-title":"Commun. Biol."},{"key":"10.1016\/j.xcrm.2026.102845_bib34","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1093\/neuonc\/nou234","article-title":"Effective treatment of diverse medulloblastoma models with mebendazole and its impact on tumor angiogenesis","volume":"17","author":"Bai","year":"2015","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.xcrm.2026.102845_bib35","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1093\/neuonc\/nor077","article-title":"Antiparasitic mebendazole shows survival benefit in 2 preclinical models of glioblastoma multiforme","volume":"13","author":"Bai","year":"2011","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.xcrm.2026.102845_bib36","doi-asserted-by":"crossref","first-page":"427","DOI":"10.3109\/0284186X.2013.844359","article-title":"Drug repositioning from bench to bedside: tumour remission by the antihelmintic drug mebendazole in refractory metastatic colon cancer","volume":"53","author":"Nygren","year":"2014","journal-title":"Acta Oncol."},{"key":"10.1016\/j.xcrm.2026.102845_bib37","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.drup.2016.03.002","article-title":"Repositioning of drugs for intervention in tumor progression and metastasis: old drugs for new targets","volume":"26","author":"Mudduluru","year":"2016","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.xcrm.2026.102845_bib38","first-page":"2963","article-title":"Mebendazole elicits a potent antitumor effect on human cancer cell lines both in vitro and in vivo","volume":"8","author":"Mukhopadhyay","year":"2002","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.xcrm.2026.102845_bib39","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s00423-003-0418-y","article-title":"Echinococcus granulosus infection: clinical presentation, medical treatment and outcome","volume":"388","author":"Kern","year":"2003","journal-title":"Langenbecks Arch. Surg."},{"key":"10.1016\/j.xcrm.2026.102845_bib40","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/0169-4758(90)90227-U","article-title":"Mode of action of benzimidazoles","volume":"6","author":"Lacey","year":"1990","journal-title":"Parasitol. Today"},{"key":"10.1016\/j.xcrm.2026.102845_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.curtheres.2016.03.001","article-title":"Mebendazole is a potential alternative in the treatment of Giardia duodenalis infection","volume":"80","author":"Ca\u00f1ete","year":"2016","journal-title":"Curr. Ther. Res. Clin. Exp."},{"key":"10.1016\/j.xcrm.2026.102845_bib42","doi-asserted-by":"crossref","first-page":"442","DOI":"10.3332\/ecancer.2014.485","article-title":"The Repurposing Drugs in Oncology (ReDO) Project","volume":"8","author":"Pantziarka","year":"2014","journal-title":"ecancermedicalscience"},{"key":"10.1016\/j.xcrm.2026.102845_bib43","first-page":"258","article-title":"The use of mebendazole in the treatment of polyparasitism","volume":"5","author":"Partono","year":"1974","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"10.1016\/j.xcrm.2026.102845_bib44","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.3390\/cancers11091284","article-title":"Mebendazole as a candidate for drug repurposing in oncology: an extensive review of current literature","volume":"11","author":"Guerini","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.xcrm.2026.102845_bib45","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1365-2125.1985.tb02617.x","article-title":"The effect of dose form on the bioavailability of mebendazole in man","volume":"19","author":"Dawson","year":"1985","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.xcrm.2026.102845_bib46","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s13046-020-01579-x","article-title":"CPI-613 rewires lipid metabolism to enhance pancreatic cancer apoptosis via the AMPK-ACC signaling","volume":"39","author":"Gao","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.xcrm.2026.102845_bib47","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/S1470-2045(17)30314-5","article-title":"Safety and tolerability of the first-in-class agent CPI-613 in combination with modified FOLFIRINOX in patients with metastatic pancreatic cancer: a single-centre, open-label, dose-escalation, phase 1 trial","volume":"18","author":"Alistar","year":"2017","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.xcrm.2026.102845_bib48","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1586\/17512433.2014.966816","article-title":"Lipoic acid and lipoic acid analogs in cancer metabolism and chemotherapy","volume":"7","author":"Bingham","year":"2014","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"10.1016\/j.xcrm.2026.102845_bib49","first-page":"91","article-title":"Translational assessment of mitochondrial dysfunction of pancreatic cancer from in vitro gene microarray and animal efficacy studies, to early clinical studies, via the novel tumor-specific anti-mitochondrial agent, CPI-613","volume":"2","author":"Lee","year":"2014","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.xcrm.2026.102845_bib50","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1124\/dmd.121.000726","article-title":"In vitro and in vivo metabolism of a novel antimitochondrial cancer metabolism agent, CPI-613, in rat and human","volume":"50","author":"Reddy","year":"2022","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.xcrm.2026.102845_bib51","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1007\/s00109-011-0785-8","article-title":"Non-redox-active lipoate derivates disrupt cancer cell mitochondrial metabolism and are potent anticancer agents in vivo","volume":"89","author":"Zachar","year":"2011","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.xcrm.2026.102845_bib52","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1158\/1078-0432.CCR-17-2282","article-title":"A Phase I study of CPI-613 in combination with high-dose cytarabine and mitoxantrone for relapsed or refractory acute myeloid leukemia","volume":"24","author":"Pardee","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.xcrm.2026.102845_bib53","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1038\/s41467-022-29039-4","article-title":"Phase II trial of cytarabine and mitoxantrone with devimistat in acute myeloid leukemia","volume":"13","author":"Anderson","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2026.102845_bib54","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.2217\/fon-2019-0209","article-title":"A Phase III open-label trial to evaluate efficacy and safety of CPI-613 plus modified FOLFIRINOX (mFFX) versus FOLFIRINOX (FFX) in patients with metastatic adenocarcinoma of the pancreas","volume":"15","author":"Philip","year":"2019","journal-title":"Future Oncol."},{"key":"10.1016\/j.xcrm.2026.102845_bib55","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.172565","article-title":"OGDH and Bcl-xL loss causes synthetic lethality in glioblastoma","volume":"9","author":"Nguyen","year":"2024","journal-title":"JCI Insight"},{"key":"10.1016\/j.xcrm.2026.102845_bib56","first-page":"2","article-title":"Ketogenic diet as a metabolic vehicle for enhancing the therapeutic efficacy of mebendazole and devimistat in preclinical pediatric glioma","volume":"2","author":"Mukherjee","year":"2023","journal-title":"BioArchives"},{"key":"10.1016\/j.xcrm.2026.102845_bib57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pneurobio.2013.04.001","article-title":"Brain development in rodents and humans: identifying benchmarks of maturation and vulnerability to injury across species","volume":"106\u2013107","author":"Semple","year":"2013","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.xcrm.2026.102845_bib58","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s13014-019-1311-3","article-title":"Positive correlation between blood glucose and radiotherapy doses to the central gustatory system in glioblastoma multiforme patients","volume":"14","author":"Duma","year":"2019","journal-title":"Radiat. Oncol."},{"key":"10.1016\/j.xcrm.2026.102845_bib59","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1093\/brain\/aww046","article-title":"Corticosteroids compromise survival in glioblastoma","volume":"139","author":"Pitter","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.xcrm.2026.102845_bib60","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12986-017-0178-2","article-title":"Press-pulse: a novel therapeutic strategy for the metabolic management of cancer","volume":"14","author":"Seyfried","year":"2017","journal-title":"Nutr. Metab."},{"key":"10.1016\/j.xcrm.2026.102845_bib61","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s11060-010-0115-y","article-title":"A novel pre-clinical in vivo mouse model for malignant brain tumor growth and invasion","volume":"99","author":"Shelton","year":"2010","journal-title":"J. Neuro Oncol."},{"key":"10.1016\/j.xcrm.2026.102845_bib62","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1038\/s41592-019-0551-3","article-title":"Comprehensive mapping of neurotransmitter networks by MALDI-MS imaging","volume":"16","author":"Shariatgorji","year":"2019","journal-title":"Nat. Methods"},{"key":"10.1016\/j.xcrm.2026.102845_bib63","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.bbabio.2018.03.012","article-title":"Mycoplasma infection and hypoxia initiate succinate accumulation and release in the VM-M3 cancer cells","volume":"1859","author":"Flores","year":"2018","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.xcrm.2026.102845_bib64","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s40170-021-00255-8","article-title":"Glutaminolysis dynamics during astrocytoma progression correlates with tumor aggressiveness","volume":"9","author":"Moreira Franco","year":"2021","journal-title":"Cancer Metab."},{"key":"10.1016\/j.xcrm.2026.102845_bib65","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.drudis.2013.10.008","article-title":"Glutaminase regulation in cancer cells: a druggable chain of events","volume":"19","author":"Katt","year":"2014","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.xcrm.2026.102845_bib66","article-title":"Targeting cellular metabolism with CPI-613 sensitizes pancreatic cancer cells to radiation therapy","volume":"8","author":"Khan","year":"2023","journal-title":"Adv. Radiat. Oncol."},{"key":"10.1016\/j.xcrm.2026.102845_bib67","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1111\/j.1471-4159.2010.06733.x","article-title":"Restricted ketogenic diet enhances the therapeutic action of N-butyldeoxynojirimycin towards brain GM2 accumulation in adult Sandhoff disease mice","volume":"113","author":"Denny","year":"2010","journal-title":"J. Neurochem."},{"key":"10.1016\/j.xcrm.2026.102845_bib68","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12986-015-0009-2","article-title":"The glucose ketone index calculator: a simple tool to monitor therapeutic efficacy for metabolic management of brain cancer","volume":"12","author":"Meidenbauer","year":"2015","journal-title":"Nutr. Metab."},{"key":"10.1016\/j.xcrm.2026.102845_bib69","doi-asserted-by":"crossref","first-page":"7986","DOI":"10.1158\/0008-5472.CAN-09-2266","article-title":"Glioblastoma cells require glutamate dehydrogenase to survive impairments of glucose metabolism or Akt signaling","volume":"69","author":"Yang","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.xcrm.2026.102845_bib70","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1007\/s00381-023-05878-4","article-title":"A foretaste for pediatric glioblastoma therapy: targeting the NF-kB pathway with DHMEQ","volume":"39","author":"Brassesco","year":"2023","journal-title":"Childs Nerv. Syst."},{"key":"10.1016\/j.xcrm.2026.102845_bib71","doi-asserted-by":"crossref","first-page":"166","DOI":"10.7150\/jca.4149","article-title":"Stemness of the CT-2A immunocompetent mouse brain tumor model: characterization in vitro","volume":"3","author":"Binello","year":"2012","journal-title":"J. Cancer"},{"key":"10.1016\/j.xcrm.2026.102845_bib72","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1046\/j.1528-1157.2001.17601.x","article-title":"Caloric restriction inhibits seizure susceptibility in epileptic EL mice by reducing blood glucose","volume":"42","author":"Greene","year":"2001","journal-title":"Epilepsia"},{"key":"10.1016\/j.xcrm.2026.102845_bib73","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.cmet.2016.12.010","article-title":"Prevention of dietary-fat-fueled ketogenesis attenuates BRAF V600E tumor growth","volume":"25","author":"Xia","year":"2017","journal-title":"Cell Metab."},{"key":"10.1016\/j.xcrm.2026.102845_bib74","doi-asserted-by":"crossref","DOI":"10.1038\/srep21807","article-title":"Long-term high fat ketogenic diet promotes renal tumor growth in a rat model of tuberous sclerosis","volume":"6","author":"Li\u015bkiewicz","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.xcrm.2026.102845_bib75","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0133633","article-title":"The ketogenic diet does not affect growth of hedgehog pathway medulloblastoma in mice","volume":"10","author":"Dang","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.xcrm.2026.102845_bib76","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1093\/neuonc\/now088","article-title":"A ketogenic diet increases transport and oxidation of ketone bodies in RG2 and 9L gliomas without affecting tumor growth","volume":"18","author":"De Feyter","year":"2016","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.xcrm.2026.102845_bib77","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/0020-7519(92)90158-H","article-title":"The effect of an oil formulation on the systemic availability of oxfendazole","volume":"22","author":"Ali","year":"1992","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.xcrm.2026.102845_bib78","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1248\/cpb.39.2158","article-title":"Improvement of dissolution and bioavailability for mebendazole, an agent for human echinococcosis, by preparing solid dispersion with polyethylene glycol","volume":"39","author":"Chiba","year":"1991","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.xcrm.2026.102845_bib79","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ijpharm.2010.10.002","article-title":"Changed crystallinity of mebendazole solid dispersion: improved anthelmintic activity","volume":"403","author":"Garc\u00eda-Rodriguez","year":"2011","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xcrm.2026.102845_bib80","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1007\/s00436-012-2954-2","article-title":"Enhanced bioavailability and cysticidal effect of three mebendazole-oil preparations in mice infected with secondary cysts of Echinococcus granulosus","volume":"111","author":"Liu","year":"2012","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.xcrm.2026.102845_bib81","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abq5925","article-title":"Discovery of DRP-104, a tumor-targeted metabolic inhibitor prodrug","volume":"8","author":"Rais","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.xcrm.2026.102845_bib82","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1158\/1541-7786.MCR-07-2159","article-title":"Mebendazole induces apoptosis via Bcl-2 inactivation in chemoresistant melanoma cells","volume":"6","author":"Doudican","year":"2008","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.xcrm.2026.102845_bib83","doi-asserted-by":"crossref","first-page":"4057","DOI":"10.1083\/jcb.201612104","article-title":"Microtubule-severing enzymes: from cellular functions to molecular mechanism","volume":"217","author":"McNally","year":"2018","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.xcrm.2026.102845_bib84","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-30158-6","article-title":"Fenbendazole acts as a moderate microtubule destabilizing agent and causes cancer cell death by modulating multiple cellular pathways","volume":"8","author":"Dogra","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.xcrm.2026.102845_bib85","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1017\/S0022149X00010105","article-title":"In vitro effects of mebendazole on the carbohydrate metabolism of Avitellina lahorea (Cestoda)","volume":"61","author":"Ahmad","year":"1987","journal-title":"J. Helminthol."},{"key":"10.1016\/j.xcrm.2026.102845_bib86","first-page":"283","article-title":"A series of transplantable rat mammary tumors with graded differentiation, growth rate, and glutaminase content","volume":"30","author":"Knox","year":"1970","journal-title":"Cancer Res."},{"key":"10.1016\/j.xcrm.2026.102845_bib87","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.3390\/cancers13092157","article-title":"Evaluation of glutaminase expression in prostate adenocarcinoma and correlation with clinicopathologic parameters","volume":"13","author":"Myint","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.xcrm.2026.102845_bib88","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1074\/jbc.M114.624619","article-title":"Metabolic cooperation of glucose and glutamine is essential for the lytic cycle of obligate intracellular parasite Toxoplasma gondii","volume":"291","author":"Nitzsche","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.xcrm.2026.102845_bib89","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-37677-x","article-title":"Viability of HepG2 and MCF-7 cells is not correlated with mitochondrial bioenergetics","volume":"13","author":"Doczi","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.xcrm.2026.102845_bib90","first-page":"606","article-title":"A ketogenic diet attenuates proliferation and stemness of glioma stem-like cells by altering metabolism resulting in increased ROS production","volume":"56","author":"Ji","year":"2019","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.xcrm.2026.102845_bib91","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1080\/07315724.1995.10718495","article-title":"Effects of a ketogenic diet on tumor metabolism and nutritional status in pediatric oncology patients: two case reports","volume":"14","author":"Nebeling","year":"1995","journal-title":"J. Am. Coll. Nutr."},{"key":"10.1016\/j.xcrm.2026.102845_bib92","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/S1470-2045(10)70166-2","article-title":"Does the existing standard of care increase glioblastoma energy metabolism?","volume":"11","author":"Seyfried","year":"2010","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.xcrm.2026.102845_bib93","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1186\/s12916-024-03775-4","article-title":"Clinical research framework proposal for ketogenic metabolic therapy in glioblastoma","volume":"22","author":"Duraj","year":"2024","journal-title":"BMC Med."},{"key":"10.1016\/j.xcrm.2026.102845_bib94","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1111\/j.1471-4159.1991.tb02021.x","article-title":"Enhanced aspartate release from hippocampal slices of epileptic (El) mice","volume":"56","author":"Flavin","year":"1991","journal-title":"J. Neurochem."},{"key":"10.1016\/j.xcrm.2026.102845_bib95","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0278-6915(86)90344-3","article-title":"Brain tumours in mice, with particular reference to astrocytoma","volume":"24","author":"Fraser","year":"1986","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.xcrm.2026.102845_bib96","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/BF03159989","article-title":"Ganglioside distribution in murine neural tumors","volume":"17","author":"Seyfried","year":"1992","journal-title":"Mol. Chem. Neuropathol."},{"key":"10.1016\/j.xcrm.2026.102845_bib97","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1158\/1535-7163.MCT-17-1148","article-title":"We're Not \u201cDON\u201d Yet: Optimal dosing and prodrug delivery of 6-diazo-5-oxo-L-norleucine","volume":"17","author":"Lemberg","year":"2018","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.xcrm.2026.102845_bib98","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1002\/ijc.25431","article-title":"Glutamine targeting inhibits systemic metastasis in the VM-M3 murine tumor model","volume":"127","author":"Shelton","year":"2010","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.xcrm.2026.102845_bib99","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.physbeh.2010.04.001","article-title":"Repetitive orogastric gavage affects the phenotype of diet-induced obese mice","volume":"100","author":"de Meijer","year":"2010","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.xcrm.2026.102845_bib100","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.taap.2012.01.025","article-title":"A less stressful alternative to oral gavage for pharmacological and toxicological studies in mice","volume":"260","author":"Walker","year":"2012","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.xcrm.2026.102845_bib101","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2025.103651","article-title":"Protocol for real-time measurement of mitochondrial bioenergetics in 3D-cultured brain tumor stem cells using the Resipher system","volume":"6","author":"Tessier","year":"2025","journal-title":"STAR Protoc."}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379126002624?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379126002624?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T22:47:21Z","timestamp":1785883641000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379126002624"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":101,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S2666379126002624"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2026.102845","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ketogenic diet as a metabolic vehicle enhancing the therapeutic efficacy of mebendazole and devimistat in juvenile syngeneic high-grade glioma","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2026.102845","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102845"}}